Report Release: The Future of the Biotechnology Industry in Greece.

Following the insightful roundtable discussions co-organized by BioInnovation Greece and Endeavor Greece on "How to Make Greece a Global Leader in Biotechnology," we are excited to share the Insights Report!

This report captures the key takeaways, challenges, proposed solutions, and opportunities identified during our discussions. It reflects the collective expertise and dedication of all participants—thank you for your valuable contributions!

We are also deeply grateful to the participants who shared their insights and expertise in shaping a vision for Greece's biotech future. Simos Simeonidis, PhD, MBA, Alex Tzoukas (Kos Biotechnology Partners), Alexandra Tolia (Angel Investor), Iraklis Kounadis, Costis Sinanidis (Neweleven Capital SA), Dimitris Anagnostou (Rose Capital), Eleni Pentafragka (Elpen Pharmaceutical Co. Inc., Athens LifeTech Park), George Karantonis (Metavallon VC), Georgios Skretas (@ResQBiotech & BRC Fleming), Georgios Pavlopoulos (BioInnovation Greece), Greg Roumeliotis (Orgenesis Inc.), Harietta Eleftherochorinou (IQVIA), Soufleri (@VIMA Science), Irinna Vavaletskou Palaiologou Palaiologou (Endeavor Greece), Kitty Iosifidou (@HDBI), Lina Nikolopoulou (Mindview), Maria-Cristina (Maritina) Grelloni (Endeavor Greece), Nick Kalliagkopoulos (BigPi Ventures), Nikos Kyrpides (BioInnovation Greece), Nicolas MILONAS (Archimedes), Roula Bachtalia (@Egg-Eurobank), , Dora Varvarigou (Hellenic Institute of Advanced Studies), Vassilis Kontozamanis (Former Alternate Minister of Health), Vassilis Pitsikalis (DeepLab AI), Victoria Kimonides (Cambridge Judge Business School)

Now, it’s time to turn these insights into action—strengthening collaboration, tackling regulatory and funding challenges, and positioning Greece as a global biotech hub. We hope this report fosters ongoing dialogue and strategic partnerships across the ecosystem.